טוען...
Serotonin-2B receptor antagonism increases the activity of dopamine and glutamate neurons in the presence of selective serotonin reuptake inhibition
Previous research has implicated the serotonin-2B (5-HT(2B)) receptor as a possible contributor to the antidepressant-like response. Aripiprazole has been successfully used in combination with selective serotonin reuptake inhibitors (SSRIs) in treatment-resistant depression and it, among all recepto...
שמור ב:
| הוצא לאור ב: | Neuropsychopharmacology |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer International Publishing
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7547697/ https://ncbi.nlm.nih.gov/pubmed/32473594 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41386-020-0723-y |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|